Human CHO-K1/VPAC1/Gα15 Stable Cell Line

[CAT#: NCL20120139CR]

VPAC1 Receptor Stable Cell Line

Species:: Human

Applications:: GPCR Screening

Cell Types:: Other Cells

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Request Pricing

Inquiry

Product Overview

Description

The vasoactive intestinal polypeptide receptor VPAC1 is Gs-coupled GPCRs expressed in the lung, prostate, peripheral blood leukocytes, liver, brain, small intestine colon, heart, spleen, placenta, kidney, thymus, and testis.

Cell Types

Other Cells

Applications

GPCR Screening

Research Areas

GPCR

Species

Human

Properties

Size

>1x10^6 Cells

Form

Frozen cells

Culture Medium

Ham's F12, 10% FBS, 100 μg/ml Hygromycin B, 200 μg/ml Zeocin

Freeze Medium

45% culture medium, 45% FBS, 10% DMSO

Receptor

VPAC1/VIP1

Family

VIP and PACAP receptor

Strain

VPAC1/Gα15 Cell Line

Cell Purity

>95%

Shipping

Dry ice

Storage

Liquid nitrogen immediately upon delivery

Handling Advice

Avoid inhalation. Avoid contact with eyes, skin, and clothing. Avoid prolonged or
repeated exposure.

Research Use Only

For research use only, not for diagnostic or therapeutic use.

Warnings

Store under recommended storage conditions (liquid nitrogen). Do not expose to high temperature. After expiration, discard all remaining reagents.

Target Details

Target

VPAC1

Official Name

VIPR1

Alternative Names

VPAC1 receptor; VIP1; VIP1/PACAP; VIP; VIP1; PVR2; PACAP type II; VPAC1; RDC1; HVR1; VPAC1R; VIP and PACAP receptor 1; MGC95067; RATVASREC; VASREC; PACAP type II receptor; PACAP-R-2; PACAP-R2; VIP-R-1; Vasopressive intestinal peptide receptor; pituitary adenylate cyclase-activating polypeptide type II receptor; vasoactive intestinal peptide receptor 1; vasoactive intestinal polypeptide receptor 1; VIP-R1; VIP receptor subtype 1; AV071699

Gene ID

7433(Human); 22354(Mouse); 24875(Rat)

Uniprot ID

P32241(Human); P97751(Mouse); P30083(Rat)

References

1. Watanabe, H., Matsushita, N., Shimizu, Y., Iikuni, S., Nakamoto, Y., Togashi, K., & Ono, M. (2019). Synthesis and characterization of a novel 18 F-labeled 2, 5-diarylnicotinamide derivative targeting orexin 2 receptor. MedChemComm, 10(12), 2126-2130.

Publications